• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1011709-12
Device Problems Material Separation (1562); Insufficient Information (3190)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/05/2023
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat the heavily calcified, moderately tortuous left anterior descending (lad) coronary artery.The 3.0x12 mm xience prime stent delivery system (sds) failed to cross the lesion as the distal shaft separated during advancement.The proximal portion of the device was simply withdrawn.There were no adverse patient effects and there was no clinically significant delay in the procedure.Another device was used to complete the procedure.Additionally, another 3.0x12 mm xience prime device was returned with a separated shaft but had only been prepped.The device had not been advanced into the patient anatomy.Follow-up with the account was performed.The account stated that the correct device was received.No additional information was provided.
 
Manufacturer Narrative
A visual and dimensional inspection was performed on the returned device.The observed material separation, which was reported as insufficient information, was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation was unable to determine a conclusive cause for the reported insufficient information (material separation).There is no indication of a product quality issue with respect to manufacture, design, or labeling.The additional xience prime device referenced in b5 is filed under a separate medwatch report number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17746216
MDR Text Key323415844
Report Number2024168-2023-10055
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 09/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/14/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011709-12
Device Lot Number3012041
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/24/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/25/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/16/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-